Treasury Licensed the Enemy's Oil Because the War Broke the Market
The United States is now officially selling its enemy's oil to pay for the war that made selling oil necessary.
The news. The narrative. The timeline.
Bureau: Delhi
The United States is now officially selling its enemy's oil to pay for the war that made selling oil necessary.
India's semaglutide patent expired March 20, and more than 50 generic drugmakers are launching versions at $14-40 a month — against America's $936 price tag.
Seven insurance mutuals withdrew war risk cover for the Persian Gulf, and every container arriving at your port now costs thousands more — the war tax nobody voted for.
Gas jumped a dollar in three weeks — the fastest peacetime surge since 2008 — and the pump is where the war comes home for voters.
The Iran war has cancelled 52,000 flights, closed Dubai's hub, and handed US carriers an $11 billion bill — and the meter is still running.
Gold futures spiked above $5,400 per ounce as the Iran war triggered the most concentrated safe-haven rush since 2020, vindicating Goldman Sachs's January forecast two months early.
At least 26 people are dead and curfews remain in force across northern Pakistan as Shia protests over the killing of Ayatollah Khamenei enter a third week with no sign of subsiding.
A JAMA Cardiology study of over 10,000 women finds premature menopause raises lifetime coronary heart disease risk by 40 percent, with Black women three times more likely to be affected.
Oil crossed $100 a barrel for the first time since Russia invaded Ukraine, and Democratic lawmakers want the companies profiting from the war to pay it back.